One of the most effective techniques to discover the novel drug i.e. ligand for receptors is by in-silico molecular docking. Thus it plays a key role in the structure based drug design. Researchers use these docking programs to know the affinity of the molecule i.e. drug which can fit to the binding site of the receptors. The journal focuses on all fields of drug design including drug discovery, drug design by rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic.
Last date updated on July, 2014